$CRCW
Crypto Co Stock $crcw

$crcw Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222023592 Filed on August 19, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q4
Revenue	$252.7K	$151.9K	$214.2K
YoY Change	131.33%	38.38%	5391.28%
Cost Of Revenue	$94.53K	$82.43K	$273.8K
YoY Change
Gross Profit	$158.2K	$69.44K	-$59.64K
YoY Change	44.8%	-36.73%
Gross Profit Margin	62.6%	45.72%	-27.85%
Selling, General & Admin	$487.2K	$1.405M	$698.1K
YoY Change	-6.19%	93.39%	25.24%
% of Gross Profit	307.97%	2024.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$32.71K	$32.71K	$10.01K
YoY Change
% of Gross Profit	20.67%	47.11%
Operating Expenses	$530.8K	$1.449M	$708.1K
YoY Change	2.19%	93.4%	27.03%
Operating Profit	-$372.6K	-$1.380M	-$767.7K
YoY Change	-9.16%	115.73%
Interest Expense	$47.29K	$600.3K	-$4.210K
YoY Change	-1223.18%	14446.09%	9.07%
% of Operating Profit
Other Income/Expense, Net	$4.100K	$66.77K	$218.5K
YoY Change	-96.98%	-91.6%	333.27%
Pretax Income	-$415.7K	-$1.913M	-$553.4K
YoY Change	49.29%	-1366.05%	9.17%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$415.7K	-$1.913M	-$553.4K
YoY Change	49.29%	-1366.05%	9.17%
Net Earnings / Revenue	-164.5%	-1259.7%	-258.4%
Basic Earnings Per Share	-$0.02	-$0.08
Diluted Earnings Per Share	-$17.80K	-$83.18K	-$24.97K
COMMON SHARES
Basic Shares Outstanding	23.15M shares	23.00M shares
Diluted Shares Outstanding	23.36M shares	23.00M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$86.06K	$19.21K	$75.70K
YoY Change	-47.8%	-96.46%	187.5%
Cash & Equivalents	$86.06K	$19.21K	$75.70K
Short-Term Investments
Other Short-Term Assets	$1.077M	$18.83K	$86.18K
YoY Change	774.51%
Inventory
Prepaid Expenses	$119.4K	$18.83K	$86.18K
Receivables
Other Receivables	$0.00		$0.00
Total Short-Term Assets	$1.163M	$38.04K	$161.9K
YoY Change	303.73%	-92.99%	435.49%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$740.5K	$740.5K	$740.5K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$989.9K
YoY Change
Total Long-Term Assets	$1.325M	$2.326M	$1.358M
YoY Change	-0.11%	75.3%
TOTAL ASSETS
Total Short-Term Assets	$1.163M	$38.04K	$161.9K
Total Long-Term Assets	$1.325M	$2.326M	$1.358M
Total Assets	$2.488M	$2.364M	$1.520M
YoY Change	54.07%	26.48%	4927.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.132M	$2.007M	$1.934M
YoY Change	20.09%	11.8%	0.2%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.577M	$2.311M	$444.5K
YoY Change	472.66%	413.56%	48.17%
Total Short-Term Liabilities	$4.709M	$4.339M	$2.378M
YoY Change	111.61%	93.27%	6.49%
LONG-TERM LIABILITIES
Long-Term Debt	$139.1K	$139.1K	$157.4K
YoY Change	-11.61%	-34.03%	-18.29%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$139.1K	$139.1K	$157.4K
YoY Change	-11.61%	-34.03%	-18.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.709M	$4.339M	$2.378M
Total Long-Term Liabilities	$139.1K	$139.1K	$157.4K
Total Liabilities	$4.848M	$4.478M	$2.536M
YoY Change	103.47%	82.34%	4.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$38.69M	-$38.27M	-$33.87M
YoY Change
Common Stock	$36.33M	$36.15M	$32.85M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.360M	-$2.114M	-$1.016M
YoY Change
Total Liabilities & Shareholders Equity	$2.488M	$2.364M	$1.520M
YoY Change	54.07%	26.48%	4927.61%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q4
OPERATING ACTIVITIES
Net Income	-$415.7K	-$1.913M	-$553.4K
YoY Change	49.29%	-1366.05%	9.17%
Depreciation, Depletion And Amortization	$32.71K	$32.71K	$10.01K
YoY Change
Cash From Operating Activities	-$178.1K	-$392.7K	-$647.0K
YoY Change	-52.81%	-143.83%	635.11%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00		$563.3K
YoY Change
Cash From Investing Activities	$0.00	$0.00	$563.3K
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	245.0K	313.1K	-5.500K
YoY Change		108.73%
NET CHANGE
Cash From Operating Activities	-178.1K	-392.7K	-647.0K
Cash From Investing Activities	0.000	0.000	563.3K
Cash From Financing Activities	245.0K	313.1K	-5.500K
Net Change In Cash	66.85K	-79.59K	-89.16K
YoY Change	-117.71%	-73.77%	1.31%
FREE CASH FLOW
Cash From Operating Activities	-$178.1K	-$392.7K	-$647.0K
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$178.1K	-$392.7K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001688126
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	CRCW	Fixed Assets FixedAssets		usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2021Q2	us-gaap	Depreciation Depreciation		usd
	us-gaap	Depreciation Depreciation		usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	CRCW	Issuance Of Common Stock For Acquisition IssuanceOfCommonStockForAcquisition		usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates		usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	City Area Code CityAreaCode	(424)
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M
	dei	Local Phone Number LocalPhoneNumber	228-9955
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity File Number EntityFileNumber	000-55726
	dei	Entity Registrant Name EntityRegistrantName	THE CRYPTO COMPANY
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4212105
	dei	Entity Address Address Line1 EntityAddressAddressLine1	23823 Malibu Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 50477
	dei	Entity Address City Or Town EntityAddressCityOrTown	Malibu
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90265
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23153919	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19214	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75699	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	18829	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	86179	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	38043	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	161878	usd
CY2022Q2	us-gaap	Goodwill Goodwill	740469	usd
CY2021Q4	us-gaap	Goodwill Goodwill	740469	usd
CY2022Q2	CRCW	Fixed Assets FixedAssets	989889	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	595835	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	617501	usd
CY2022Q2	us-gaap	Assets Assets	2364236	usd
CY2021Q4	us-gaap	Assets Assets	1519848	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2006699	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1933800	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	21000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	2310998	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	444500	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4338697	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2378300	usd
CY2022Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2022Q2	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	14100	usd
CY2021Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	32365	usd
CY2022Q2	us-gaap	Liabilities Liabilities	4477797	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2535665	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23191419	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23191419	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22205248	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22205248	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	23191	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	22205	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36129188	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32830496	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38265940	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33868518	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2113561	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1015817	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2364236	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1519848	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	151869	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	109745	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	294381	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	111145	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	82433	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	176211	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	69436	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	109745	usd
	us-gaap	Gross Profit GrossProfit	118170	usd
	us-gaap	Gross Profit GrossProfit	111145	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	506390	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	533960	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1123370	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	656369	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10833	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22491	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21666	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22491	usd
CY2022Q2	us-gaap	Depreciation Depreciation	32708	usd
	us-gaap	Depreciation Depreciation	43611	usd
CY2022Q2	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee	109447	usd
CY2021Q2	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee	2470	usd
	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee	272447	usd
	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee	2470	usd
CY2022Q2	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	789602	usd
CY2021Q2	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	190289	usd
	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	1512063	usd
	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	331124	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	1448980	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	749210	usd
	us-gaap	Costs And Expenses CostsAndExpenses	2973157	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1012454	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1379545	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-639465	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2854987	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-901309	usd
CY2022Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	66765	usd
CY2021Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	794700	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	81765	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	955508	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	600317	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	4127	usd
	us-gaap	Interest Expense InterestExpense	1624200	usd
	us-gaap	Interest Expense InterestExpense	7949	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1913096	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	151108	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4397422	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	46250	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1913096	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	151108	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4397422	usd
	us-gaap	Net Income Loss NetIncomeLoss	46250	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.08
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.01
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.19
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.00
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23000073	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22136852	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22752500	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21989445	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-2395647	usd
	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	20929	usd
CY2021Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.00
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	825001	usd
	CRCW	Stock Compensation Expense In Connection With Issuance Of Common Stock StockCompensationExpenseInConnectionWithIssuanceOfCommonStock	312665	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	604317	usd
	us-gaap	Net Income Loss NetIncomeLoss	46250	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-586486	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1015817	usd
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3.28
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26240	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26240	usd
	CRCW	Stock Compensation Expense In Connection With Issuance Of Common Stock StockCompensationExpenseInConnectionWithIssuanceOfCommonStock	1740760	usd
	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	43750	usd
	CRCW	Adjustments To Additional Paid In Capital Debt Discount For Warrants AdjustmentsToAdditionalPaidInCapitalDebtDiscountForWarrants	1488927	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4397422	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2113561	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4397422	usd
	us-gaap	Net Income Loss NetIncomeLoss	46250	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	65277	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22491	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1784510	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	333594	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1488927	usd
	CRCW	Issuance Of Common Stock For Acquisition IssuanceOfCommonStockForAcquisition	604317	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3900	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-67350	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	72900	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-138361	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	21000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-897458	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	872191	usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	1349457	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1033500	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1033500	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1349457	usd
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-18265	usd
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	18265	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1866498	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	150000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	26240	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	825000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1874473	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	993265	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-56485	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	515999	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	75699	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26326	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19214	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	542325	usd
	us-gaap	Cost Of Revenue CostOfRevenue	19000	usd
CY2022Q2	us-gaap	Cash Cash	19214	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4397422	usd
	CRCW	Working Capital WorkingCapital	4300654	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38265940	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zgsgs57DthBe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zL1nvIQoGE1c">Use of estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s significant estimates and assumptions include but are not limited to the valuation allowances of deferred taxes, and share-based compensation expenses. Actual results may differ from these estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on the Company’s operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2281429	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.26
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5155003	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2281429	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.26
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	5155003	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2022Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1349457	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	699457	usd
CY2022Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	650000	usd
	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Intangibles BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles	54166	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21666	usd
CY2022Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2022Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2281429	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2281429	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.26
	CRCW	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Beginning Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingBeginningWeightedAverageRemainingContractualTerm2	P4Y3M
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5155003	usd
	us-gaap	Payments For Rent PaymentsForRent	0	usd
	us-gaap	Payments For Rent PaymentsForRent	0	usd

Files In Submission

Name	View Source	Status
0001493152-22-023592-index-headers.html	Edgar Link	pending
0001493152-22-023592-index.html	Edgar Link	pending
0001493152-22-023592.txt	Edgar Link	pending
0001493152-22-023592-xbrl.zip	Edgar Link	pending
crcw-20220630.xsd	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-1_001.jpg	Edgar Link	pending
ex10-1_002.jpg	Edgar Link	pending
ex10-1_003.jpg	Edgar Link	pending
ex10-1_004.jpg	Edgar Link	pending
ex10-1_005.jpg	Edgar Link	pending
ex10-1_006.jpg	Edgar Link	pending
ex10-1_007.jpg	Edgar Link	pending
ex10-1_008.jpg	Edgar Link	pending
ex10-1_009.jpg	Edgar Link	pending
ex10-1_010.jpg	Edgar Link	pending
ex10-1_011.jpg	Edgar Link	pending
ex10-1_012.jpg	Edgar Link	pending
ex10-1_013.jpg	Edgar Link	pending
ex10-1_014.jpg	Edgar Link	pending
ex10-1_015.jpg	Edgar Link	pending
ex10-1_016.jpg	Edgar Link	pending
crcw-20220630_def.xml	Edgar Link	unprocessable
crcw-20220630_lab.xml	Edgar Link	unprocessable
crcw-20220630_pre.xml	Edgar Link	unprocessable
ex10-1_017.jpg	Edgar Link	pending
ex10-1_018.jpg	Edgar Link	pending
ex10-1_019.jpg	Edgar Link	pending
ex10-1_020.jpg	Edgar Link	pending
ex10-1_021.jpg	Edgar Link	pending
ex10-1_022.jpg	Edgar Link	pending
ex10-1_023.jpg	Edgar Link	pending
ex10-1_024.jpg	Edgar Link	pending
ex10-1_025.jpg	Edgar Link	pending
ex10-1_026.jpg	Edgar Link	pending
ex10-1_027.jpg	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex10-2_001.jpg	Edgar Link	pending
ex10-2_002.jpg	Edgar Link	pending
ex10-2_003.jpg	Edgar Link	pending
ex10-2_004.jpg	Edgar Link	pending
ex10-2_005.jpg	Edgar Link	pending
ex10-2_006.jpg	Edgar Link	pending
ex10-2_007.jpg	Edgar Link	pending
ex10-2_008.jpg	Edgar Link	pending
ex10-2_009.jpg	Edgar Link	pending
ex10-2_010.jpg	Edgar Link	pending
ex10-2_011.jpg	Edgar Link	pending
ex10-2_012.jpg	Edgar Link	pending
ex10-2_013.jpg	Edgar Link	pending
ex10-2_014.jpg	Edgar Link	pending
ex10-2_015.jpg	Edgar Link	pending
ex10-2_016.jpg	Edgar Link	pending
ex10-2_017.jpg	Edgar Link	pending
ex10-2_018.jpg	Edgar Link	pending
ex10-2_019.jpg	Edgar Link	pending
ex10-3.htm	Edgar Link	pending
ex10-3_001.jpg	Edgar Link	pending
ex10-3_002.jpg	Edgar Link	pending
ex10-3_003.jpg	Edgar Link	pending
ex10-3_004.jpg	Edgar Link	pending
ex10-3_005.jpg	Edgar Link	pending
ex10-3_006.jpg	Edgar Link	pending
ex10-3_007.jpg	Edgar Link	pending
ex10-3_008.jpg	Edgar Link	pending
ex10-3_009.jpg	Edgar Link	pending
ex10-3_010.jpg	Edgar Link	pending
ex10-3_011.jpg	Edgar Link	pending
ex10-3_012.jpg	Edgar Link	pending
ex10-3_013.jpg	Edgar Link	pending
ex10-3_014.jpg	Edgar Link	pending
ex10-3_015.jpg	Edgar Link	pending
ex10-3_016.jpg	Edgar Link	pending
ex10-3_017.jpg	Edgar Link	pending
ex10-3_018.jpg	Edgar Link	pending
ex10-3_019.jpg	Edgar Link	pending
ex10-3_020.jpg	Edgar Link	pending
ex10-3_021.jpg	Edgar Link	pending
ex10-3_022.jpg	Edgar Link	pending
ex10-3_023.jpg	Edgar Link	pending
ex10-3_024.jpg	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex10-4_001.jpg	Edgar Link	pending
ex10-4_002.jpg	Edgar Link	pending
ex10-4_003.jpg	Edgar Link	pending
ex10-4_004.jpg	Edgar Link	pending
ex10-4_005.jpg	Edgar Link	pending
ex10-4_006.jpg	Edgar Link	pending
ex10-4_007.jpg	Edgar Link	pending
ex10-4_008.jpg	Edgar Link	pending
ex10-4_009.jpg	Edgar Link	pending
ex10-4_010.jpg	Edgar Link	pending
ex10-4_011.jpg	Edgar Link	pending
ex10-5.htm	Edgar Link	pending
ex10-5_001.jpg	Edgar Link	pending
ex10-5_002.jpg	Edgar Link	pending
ex10-5_003.jpg	Edgar Link	pending
ex10-5_004.jpg	Edgar Link	pending
ex10-5_005.jpg	Edgar Link	pending
ex10-5_006.jpg	Edgar Link	pending
ex10-5_007.jpg	Edgar Link	pending
ex10-5_008.jpg	Edgar Link	pending
ex10-5_009.jpg	Edgar Link	pending
ex10-5_010.jpg	Edgar Link	pending
ex10-5_011.jpg	Edgar Link	pending
ex10-5_012.jpg	Edgar Link	pending
ex10-5_013.jpg	Edgar Link	pending
ex10-5_014.jpg	Edgar Link	pending
ex10-5_015.jpg	Edgar Link	pending
ex10-5_016.jpg	Edgar Link	pending
ex10-5_017.jpg	Edgar Link	pending
ex10-5_018.jpg	Edgar Link	pending
ex10-5_019.jpg	Edgar Link	pending
ex10-5_020.jpg	Edgar Link	pending
ex10-5_021.jpg	Edgar Link	pending
ex10-5_022.jpg	Edgar Link	pending
ex10-5_023.jpg	Edgar Link	pending
ex10-5_024.jpg	Edgar Link	pending
ex10-5_025.jpg	Edgar Link	pending
ex10-5_026.jpg	Edgar Link	pending
ex10-5_027.jpg	Edgar Link	pending
ex10-5_028.jpg	Edgar Link	pending
ex10-6.htm	Edgar Link	pending
ex10-6_001.jpg	Edgar Link	pending
ex10-6_002.jpg	Edgar Link	pending
ex10-6_003.jpg	Edgar Link	pending
ex10-6_004.jpg	Edgar Link	pending
ex10-6_005.jpg	Edgar Link	pending
ex10-6_006.jpg	Edgar Link	pending
ex10-6_007.jpg	Edgar Link	pending
ex10-6_008.jpg	Edgar Link	pending
ex10-6_009.jpg	Edgar Link	pending
ex10-6_010.jpg	Edgar Link	pending
ex10-6_011.jpg	Edgar Link	pending
ex10-6_012.jpg	Edgar Link	pending
ex10-6_013.jpg	Edgar Link	pending
ex10-6_014.jpg	Edgar Link	pending
ex10-6_015.jpg	Edgar Link	pending
ex10-6_016.jpg	Edgar Link	pending
ex10-6_017.jpg	Edgar Link	pending
ex10-6_018.jpg	Edgar Link	pending
ex10-6_019.jpg	Edgar Link	pending
ex10-7.htm	Edgar Link	pending
ex10-7_001.jpg	Edgar Link	pending
ex10-7_002.jpg	Edgar Link	pending
ex10-7_003.jpg	Edgar Link	pending
ex10-7_004.jpg	Edgar Link	pending
ex10-7_005.jpg	Edgar Link	pending
ex10-7_006.jpg	Edgar Link	pending
ex10-7_007.jpg	Edgar Link	pending
ex10-7_008.jpg	Edgar Link	pending
ex10-7_009.jpg	Edgar Link	pending
ex10-7_010.jpg	Edgar Link	pending
ex10-7_011.jpg	Edgar Link	pending
ex10-7_012.jpg	Edgar Link	pending
ex10-7_013.jpg	Edgar Link	pending
ex10-7_014.jpg	Edgar Link	pending
ex10-7_015.jpg	Edgar Link	pending
ex10-7_016.jpg	Edgar Link	pending
ex10-7_017.jpg	Edgar Link	pending
ex10-7_018.jpg	Edgar Link	pending
ex10-7_019.jpg	Edgar Link	pending
ex10-7_020.jpg	Edgar Link	pending
ex10-7_021.jpg	Edgar Link	pending
ex10-7_022.jpg	Edgar Link	pending
ex10-7_023.jpg	Edgar Link	pending
ex10-7_024.jpg	Edgar Link	pending
ex10-8.htm	Edgar Link	pending
ex10-8_001.jpg	Edgar Link	pending
ex10-8_002.jpg	Edgar Link	pending
ex10-8_003.jpg	Edgar Link	pending
ex10-8_004.jpg	Edgar Link	pending
ex10-8_005.jpg	Edgar Link	pending
ex10-8_006.jpg	Edgar Link	pending
ex10-8_007.jpg	Edgar Link	pending
ex10-8_008.jpg	Edgar Link	pending
ex10-8_009.jpg	Edgar Link	pending
ex10-8_010.jpg	Edgar Link	pending
ex10-8_011.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
crcw-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRCW
Crypto Co Stock $crcw

2022 Q3 Form 10-Q Financial Statement

#000149315222023592 Filed on August 19, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRCW Crypto Co Stock $crcw

2022 Q3 Form 10-Q Financial Statement

#000149315222023592 Filed on August 19, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRCW
Crypto Co Stock $crcw